Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-11-06
2007-11-06
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024100, C435S006120, C514S04400A
Reexamination Certificate
active
10609150
ABSTRACT:
Inhibitors of human Sos1, including antisense oligonucleotides, methods, and compositions specific for human Sos1, are provided. Methods of using the compositions for modulating Sos1 expression and for regulating cell growth, particularly tumor cell growth, are also provided.
REFERENCES:
patent: 5656595 (1997-08-01), Schweighoffer et al.
patent: 6455307 (2002-09-01), McKay et al.
patent: WO 93/21314 (1993-10-01), None
Hart, T.C.,A Mutation in the SOS1 Gene Causes Hereditary Gingival Fibromatosis Type 1, Am. J. Hum. Genet. 70:943-954, 2002.
Nyhus, J.K.,Direct in vivo Transfection of Antisense Fas-ligand Reduces Tumor Growth and Invasion, Gene Therapy 8:209-214, 2001.
Qian, X. et al.,The Sos1 and Sos2 Ras-specific Exchange Factors: Differences in Placental Expression and Signaling Properties, The EMBO Journal 19:642-654, 2000.
Sibilia, M. et al.,The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development, CELL 102:211-220, 2000.
Branch, A.D.,A Good Antisense Molecule is Hard to Find, TIBS 23:45-50, 1998.
Anazodo, M.I. et al.,Relative Levels of Inhibition of p24 Gene Expression by Different 20-mer antisense Oligonucleotide Sequences Targeting Nucleotides +1129 to +1268 of the HIV-1 gag Genome: an Analysis of Nechanism, Biochem. Biophys. Res Commun. 229:305-309, 1996.
Hirota, Y. et al.,p53 Antisense Oligonucleotide Inhibits Growth of Human Colon Tumor and Normal Cell Lines, Jpn. J. Cancer Res. 87:735-742, 1996.
Giles, R.V. et al.,Single Base Discrimination for Ribonuclease H-Dependent Antisense Effects Within Intact Human Leukemia Cells, Nucleic Acids Research 23:954-961, 1995.
Gishizky, M.L.,Tyrosine Kinase Induced Mitogenesis. Breaking the Link with Cancer, in Annual Reports in Medicinal Chemistry 30:247-253 (Academic Press, Inc., 1995).
Pandey, P. et al.,Association of the DF3/Muc1 Breast Cancer Antigen with Grb2 and the Sos/Ras Exchange Protein, Can Res. 55:4000-4003, 1995.
Witty, J.P. et al., Modulation of Matrolysin Levels in Colon Carcinoma Cell Lines Affects Tumorigenicity in vivo, Can. Res. 54:4805-4812, 1994.
Haselhoff, J. et al.,Simple RNA enzymes with New and Highly Specific Endoribonuclease Activities, NATURE 334:585-591, 1988.
Walbot, V. et al.,Plant Development and Ribozymes for Pathogens, NATURE 334:196-197, 1988.
Forster, A.C. et al.,Self-Cleavage of Plus and Minus RNAs of a Virusoid and a Structural Model for the Active Sites, CELL 49:211-220, 1987.
Uhlenbeck, O.C.,A Small Catalytic Oligoribonucleotide, NATURE 328:596-600, 1987.
Weintraub et al.,Antisense RNA and DNA: Molecules That Bind With Specific Messenger RNA's Can Selectively Turn Off Genes. Eventually Certain Diseases May Be Treated Wtih Them; Today Antisense Molecules Are Valuable Research Tools, Scientific American, 40-45, 1990.
Chin, Andrew, CD-ROM document, entitled “On the Preparation and Utilization of Isolated and Purified Oligonucleotides,” including copy of letter, dated May 12, 2005 from Andrew Chin.
Fantl Wendy J.
Jaitner Birgit K.
Abrahamson Susan L.
Chiron Corporation
Harbin Alisa A.
McGarry Sean
Potter Jane E. R.
LandOfFree
Sos1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sos1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sos1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868373